N/A
Completed N=49
Alcohol Monitor Validation
Source: ClinicalTrials.gov NCT03617705 ↗Enrolled (actual)
49
Serious AEs
0.0%
Results posted
Jun 2023
Primary outcomePrimary: Transdermal Alcohol Concentration (TAC) — 38.3; 95.8 ug/L
Summary
This study will validate a wrist-worn alcohol monitor (BACtrack Skyn) in both laboratory and real-life settings.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Transdermal Alcohol Concentration (TAC) |
38.3; 95.8 | — |
Eligibility Criteria
Inclusion Criteria
- HIV+ consumers of alcohol; self-reported ≥ 5 days with at least 1 alcoholic drink, and ≥1days with at least 3 drinks
- HIV- consumers of alcohol; self-reported ≥ 5 days with at least 1 alcoholic drink, and ≥1days with at least 3 drinks
Exclusion Criteria
- non-drinkers
- recent addiction treatment or treatment seeking
- urine positive for illegal drugs except THC (not applicable to those who are only invited to do field test);
- past & current alcohol withdrawal
- severe alcohol use disorder (DSM-5)
- meeting criteria for current nicotine dependence (not applicable to field only participants) or current substance use disorder (excluding mild cannabis use disorder and mild/moderate alcohol use disorder)
- medical conditions (other than HIV) contraindicating alcohol
- pregnancy/breastfeeding in women
- psychosis or other severe psychiatric conditions.
Data sourced from ClinicalTrials.gov (NCT03617705). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.